Search Results - Lange, E.

Patient’s thoughts and expectations about centres of expertise for PKU by Wegberg, Anna van (Author) , MacDonald, A. (Author) , Abeln, D. (Author) , Hagedorn, T. S. (Author) , Lange, E. (Author) , Trefz, Friedrich K. (Author) , van Vliet, D. (Author) , van Spronsen, F. J. (Author) ,

• Verlag, lizenzpflichtig, Volltext

Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymp... by Fürstenau, Moritz (Author) , Bahlo, J. (Author) , Fink, A. M. (Author) , Lange, E. (Author) , Dreger, Peter (Author) , Dreyling, M. (Author) , Hess, G. (Author) , Ritgen, M. (Author) , Kneba, M. (Author) , Döhner, H. (Author) , Stilgenbauer, S. (Author) , Wendtner, C. M. (Author) , Goede, V. (Author) , Fischer, K. (Author) , Böttcher, S. (Author) , Hallek, M. (Author) , Eichhorst, B. (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine by Schlenk, Richard Friedrich (Author) , Weber, Daniel (Author) , Herr, Wolfgang (Author) , Wulf, Gerald (Author) , Salih, Helmut R. (Author) , Derigs, H. G. (Author) , Kündgen, Andrea (Author) , Ringhoffer, Mark (Author) , Hertenstein, B. (Author) , Martens, Uwe Marc (Author) , Griesshammer, Martin (Author) , Bernhard, H. (Author) , Krauter, Jürgen (Author) , Girschikofsky, M. (Author) , Wolf, D. (Author) , Lange, E. (Author) , Westermann, J. (Author) , Koller, E. (Author) , Kremers, S. (Author) , Wattad, M. (Author) , Heuser, Michael (Author) , Thol, Felicitas (Author) , Göhring, Gudrun (Author) , Haase, D. (Author) , Teleanu, V. (Author) , Gaidzik, Verena Ingeborg (Author) , Benner, Axel (Author) , Döhner, Konstanze (Author) , Ganser, Arnold (Author) , Paschka, Peter (Author) , Döhner, Hartmut (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia by Pfeifer, Heike (Author) , Wassmann, B. (Author) , Bethge, W. (Author) , Dengler, Jolanta (Author) , Bornhäuser, M. (Author) , Stadler, M. (Author) , Beelen, D. (Author) , Vucinic, V. (Author) , Burmeister, T. (Author) , Stelljes, M. (Author) , Faul, C. (Author) , Dreger, Peter (Author) , Kiani, A. (Author) , Schäfer-Eckart, K. (Author) , Schwerdtfeger, R. (Author) , Lange, E. (Author) , Kubuschok, B. (Author) , Horst, H. A. (Author) , Gramatzki, M. (Author) , Brück, P. (Author) , Serve, H. (Author) , Hoelzer, D. (Author) , Gökbuget, N. (Author) , Ottmann, O. G. (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext